Syros Pharmaceuticals said it plans to wind down its operations, according to a Securities and Exchange Commission filing. The Cambridge, Mass., company said it would proceed with a voluntary ...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) (the “Company”) today announced that its Board of Directors (the “Board”) has approved and the Company intends to proceed with the voluntary ...
Syros Pharmaceuticals, which said in November it would cut most of its workforce, said on Friday it will wind down operations. The company's stock dropped 45% to 8 cents in after-hours trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback